<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">tocytosis (mast cell disease). In: Swerdlow P, Campo P, Harris P, editors. World Health Organization (WHO) classification of tumours pathology and genetics of tumours of the haematopoietic and lymphoid tissues, 2. Lyon: IARC Press; 2008:54-63</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2015-08-20">August 20, 2015</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><surname>Escribano L, Alvarez-Twose</surname></persName>
						</author>
						<author>
							<persName><forename type="first">L</forename><surname>Sanchez-Munoz</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Garcia-Montero</forename><surname>A, N Uñez R</surname></persName>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="department">Department of Dermatology</orgName>
								<orgName type="institution">University of Cologne</orgName>
								<address>
									<settlement>Cologne</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Hematology and Oncology</orgName>
								<orgName type="department" key="dep2">Department of Dermatology and Allergy</orgName>
								<orgName type="institution" key="instit1">III. Medical Clinic</orgName>
								<orgName type="institution" key="instit2">Medical University of Mannheim</orgName>
								<address>
									<settlement>Mannheim</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<orgName type="institution">Hannover Med-ical School</orgName>
								<address>
									<settlement>Hannover</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<orgName type="department">Molecular Oncology and Pharmacology</orgName>
								<orgName type="institution" key="instit1">LBPA CNRS UMR8113</orgName>
								<orgName type="institution" key="instit2">Ecole Normale Sup erieure de Cachan</orgName>
								<address>
									<settlement>Cachan</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff4">
								<orgName type="department">Department of Dermatology</orgName>
								<orgName type="institution">University of Luebeck</orgName>
								<address>
									<settlement>Luebeck</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff5">
								<address>
									<settlement>Almeida</settlement>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">tocytosis (mast cell disease). In: Swerdlow P, Campo P, Harris P, editors. World Health Organization (WHO) classification of tumours pathology and genetics of tumours of the haematopoietic and lymphoid tissues, 2. Lyon: IARC Press; 2008:54-63</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2015-08-20">August 20, 2015</date>
						</imprint>
					</monogr>
					<idno type="MD5">A2E99616E15BA3CC1C4BB8D95B67B4F3</idno>
					<idno type="DOI">10.1016/j.jaci.2015.07.006</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:43+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>K.H. Disclosure of potential conflicts of interest: M. Arock has patents through CNRS (Centre national de la recherche scientifique) and ENS (Ecole normale sup erieure de Cachan) Cachan for human mast cell lines, preparations, and uses (WO 2013064639 A1).</s><s>U. Raap has received research support and payment for lectures from Novartis Pharma.</s><s>K. Hartmann has consultant arrangements with Novartis; has received payment for lectures from Abbvie, Biogen, and Novartis; and has received a research grant from Novartis.</s><s>The rest of the authors declare that they have no relevant conflicts of interest.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>IL-10-producing forkhead box protein 3-negative regulatory T cells inhibit B-cell responses and are involved in systemic lupus erythematosus</head><p><s>To the Editor:</s></p><p><s>IL-10 has anti-inflammatory properties but is also a B-cell growth and differentiation factor. <ref type="bibr" target="#b0">1,</ref><ref type="bibr" target="#b1">2</ref></s><s>B-cell responses are inhibited by a specialized population of follicular forkhead box protein 3 (Foxp3) <ref type="bibr" target="#b0">1</ref> regulatory T (Treg) cells, <ref type="bibr" target="#b2">3</ref> whereas in vitro-generated, Foxp3 2 , IL-10-producing type 1 Treg cells (T R 1 cells) can promote B-cell responses. <ref type="bibr" target="#b3">4</ref></s><s>However, because it is unknown how to identify human T R 1 cells in lymphoid organs, their role in Bcell response is incompletely understood. <ref type="bibr" target="#b4">5</ref></s><s>e previously identified T R 1-like cells with IL-10-dependent regulatory functions among CD4 1 CD25 2 IL-7 receptor (IL-7R) <ref type="bibr" target="#b1">2</ref> T cells in human blood. <ref type="bibr" target="#b5">6</ref></s><s>These IL-7R 2 T cells were enriched in tonsils (Fig <ref type="figure" target="#fig_5">1, A</ref>), but only a minor fraction produced IL-10 (Fig 1 <ref type="figure">, B</ref>).</s><s>In contrast to CD25 <ref type="bibr" target="#b0">1</ref> Treg cells, these IL-10 1 IL-7R 2 T R 1-like cells produced high levels of IFN-g and IL-21 in tonsils (Fig 1 <ref type="figure">, C</ref>) and blood (see Fig <ref type="figure" target="#fig_5">E1, A</ref>, in this article's Online Repository at www.jacionline.org) <ref type="bibr" target="#b5">6</ref></s><s>and low levels of IL-4 (data not shown).</s><s>Similar to CD25 <ref type="bibr" target="#b0">1</ref> Treg cells, however, they expressed high levels of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4), intermediate levels of inducible costimulator (ICOS), and low levels of CD40 ligand (CD40L; Fig <ref type="figure" target="#fig_5">1, D</ref>, and see Fig <ref type="figure" target="#fig_5">E1, A</ref>).</s><s>Because the absence of IL-7R expression is insufficient to define T R 1-like cells in tonsils, <ref type="bibr" target="#b6">7</ref> we searched for additional phenotypic markers.</s><s>T R 1-like cells were heterogeneous for CD45RA expression (see Fig <ref type="figure" target="#fig_5">E1, B</ref>) but coexpressed CCR5 and programmed cell death protein 1 (PD-1; Fig <ref type="figure" target="#fig_5">1, E and F</ref>, and see Figs <ref type="figure" target="#fig_5">E1, C</ref>, and E2, A, in this article's Online Repository at www.jacionline.org).</s><s>Conversely, they lacked CCR6, suggesting that they were distinct from CCR6 1 IL-7R 1 T cells, which produce IL-10 on weak T-cell receptor (TCR) stimulation. <ref type="bibr" target="#b7">8</ref></s><s>Consistently, unlike IL-7R 1 T cells, T R 1-like cells required CD28 costimulation to produce IL-10 and IFN-g (see Fig E2 <ref type="figure">, B</ref>).  control cells did not.</s><s>Thus the described phenotype strongly enriches for IL-10-producing Treg cells and discriminates them from conventional IL-7R 2 effector and IL-10-producing memory T cells. <ref type="bibr" target="#b6">7,</ref><ref type="bibr" target="#b7">8</ref></s><s>Therefore this strategy is suited for immune monitoring and purification of T R 1-like cells from blood and lymphoid tissues.</s></p><p><s>Having identified a specific phenotype of T R 1-like cells, we were now able to analyze the role of purified tonsillar T R 1-like cells in the B-cell response.</s><s>Similar to CD25 1 Treg cells, T R 1-like cells did not efficiently induce B-cell proliferation (see Fig <ref type="figure">E3, A</ref> The helper effects of cytokines on B cells require concurrent CD40 stimulation, which is provided by CD40L-expressing helper T cells. <ref type="bibr" target="#b8">9</ref></s><s>Consistently, the helper capacities of T-cell subsets strictly correlated with CD40L expression (Fig 2 <ref type="figure">, B</ref>). Importantly, exogenous CD40 was sufficient to induce IgG production from B cells cocultured with T R 1-like cells but not with CD25 1 Treg cells (Fig 2 <ref type="figure">, C</ref>).</s></p><p><s>In conclusion, although T R 1-like cells produce high levels of IL-10 and IL-21, they do not help B cells because they do not upregulate CD40L.</s><s>Therefore the lack of CD40L is a key feature of T cells with B-regulatory functions and a relevant criterion to distinguish IL-10-producing regulatory from helper T cells.</s><s>Murine CCR5 1 PD-1 1 T R 1 cells also lacked CD40L expression and inhibited B-cell antibody production in vitro (data not shown).</s><s>To address whether T R 1 cells could inhibit B-cell responses in vivo, we cotransferred in vitrogenerated CCR5 1 PD-1 1 IL-10 eGFP1 Foxp3 RFP2 T R 1 cells from TCR-transgenic OT-IIxIL-10 eGFP xFoxp3 RFP double-reporter mice with B cells alone or with splenic OT-II-CD4 1 T cells into Rag1 2/2 mice immunized with OVA and measured IgG induction in the serum.</s><s>The transfer of OT-II-CD4 1 T cells but not OT-II-CCR5 1 PD-1 1 T R 1 cells induced production of OVA-specific IgG 1 (Fig 2 <ref type="figure">, E</ref>), and the cotransfer of T R 1 cells significantly reduced the concentrations of OVA-specific antibodies induced by CD4 1 helper T cells.</s><s>Notably, T R 1 cells and Foxp3 1 Treg cells had a similar capacity to suppress IgG production in vivo (see Fig <ref type="figure">E3, H</ref>).</s><s>We conclude that human and mouse T R 1 cells lack B-helper functions and inhibit B-cell responses in vitro and in vivo.</s></p><p><s>Finally, we asked whether T R 1-like cells might play a role in antibody-driven autoimmune disorders.</s><s>Therefore we analyzed the frequencies and functions of circulating T R 1-like cells in patients with systemic lupus erythematosus (SLE; see Table <ref type="table" target="#tab_1">E1</ref> in this article's Online Repository at www.jacionline.org),</s><s>who have a prototypic autoantibody-driven pathology.</s><s>We observed an increased frequency of T R 1-like cells but not CD25 1 Treg cells among circulating CD4 1 T cells (Fig 2 <ref type="figure">, F</ref>), in particular in patients with active disease, according to the Safety of Estrogens in Lupus Erythematosus National Assessment (SELENA) Systemic Lupus Erythematosus Disease Activity (SLEDAI) score.</s></p><p><s>In a smaller cohort we also detected an increased frequency of IL-7R 2 IL-10 1 CD40L 2 T cells in patients with active disease (see Fig <ref type="figure">E3, I</ref>).</s><s>We next analyzed the suppressive capacities of Treg cell subsets in patients with SLE.</s><s>T R 1-like cells from patients with SLE did not inhibit IgG production (Fig 2 <ref type="figure">, G</ref>), whereas T R 1-like cells from healthy donors and CD25 1 Treg cells from patients with SLE were suppressive.</s><s>The effects of T R 1-like cells on IgG production varied between individual patients, but in the majority of patients, including those with nonactive disease, T R 1-like cells were not suppressive (see Fig E3 <ref type="figure">, J</ref>).</s></p><p><s>In conclusion, T R 1-like cells have a characteristic phenotype, promote B-cell tolerance independently of IL-10, and are involved in SLE and potentially also in other autoimmune diseases associated with autoantibody production.</s><s>These findings have important implications for the regulation of B-cell tolerance and suggest that therapeutic transfer of functional T R 1-like cells, as recently established for patients with inflammatory bowel disease, <ref type="bibr" target="#b10">11</ref> might inhibit autoantibody generation in patients with SLE.</s></p><p><s>Neonatal-onset T 2 B 2 NK 1 severe combined immunodeficiency and neutropenia caused by mutated phosphoglucomutase 3</s></p><p><s>To the Editor:</s></p><p><s>Phosphoglucomutase 3 (PGM3) defects were recently identified as a cause of hyper-IgE syndrome (HIES). <ref type="bibr" target="#b0">1,</ref><ref type="bibr" target="#b1">2</ref></s><s>HIES is classically characterized by recurrent staphylococcal skin abscesses, sinopulmonary infections, and severe eczema with increased plasma IgE concentrations. <ref type="bibr" target="#b2">3</ref></s><s>The HIES phenotype can be caused by mutations within a growing list of genes: signal transducer and activator of transcription 3 (STAT3), dedicator of cytokinesis 8 (DOCK8), tyrosine kinase 2 (TYK2), and PGM3.</s></p><p><s>PGM3 catalyzes a key step in uridine diphosphate N-acetylglucosamine synthesis ubiquitously used in glycosylation. <ref type="bibr" target="#b3">4</ref> PGM3 was attributed no role in immunodeficiency until 2 groups independently described a homogeneous presentation of HIES in 17 young adults carrying 6 different PGM3 mutations demonstrated to decrease enzymatic function. <ref type="bibr" target="#b0">1,</ref><ref type="bibr" target="#b1">2</ref></s><s>The reports made a compelling argument that defective PGM3 causes HIES.</s><s>Shortly afterward, Stray-Pedersen et al 5 described 3 unrelated infants also carrying PGM3 mutations and presenting with homogeneous immunodeficiency.</s><s>This immunodeficiency debuted soon after birth as T 2 B 2 natural killer (NK)-positive severe combined immunodeficiency (SCID) together with neutropenia.</s></p><p><s>To increase knowledge about PGM3 and immunodeficiency, we report the clinical course and detailed laboratory investigations of yet another infant carrying mutated PGM3.</s></p><p><s>The boy was born at term in Denmark as the first child of Syrian-Kurdish parents without known family history of consanguinity, immunodeficiency, or stillbirth.</s><s>The boy was marginally small for gestational age (birth weight, 3105 g, 5th-10th percentile; length 47 cm, 25th percentile) with dysmorphic facial features: downturned corners of the mouth (</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Human samples and patients</head><p><s>Buffy coat blood from healthy donors and surgically removed tonsil specimens from pediatric patients were obtained from the IRCCS Policlinico Ospedale Maggiore, Milan, Italy, and the Charit e Hospital in Berlin and the DRK (Deutsches Rotes Kreuz), Germany.</s><s>Peripheral blood from patients with SLE was obtained from the Istituto G. Pini, Milan, Italy.</s><s>All patients fulfilled the American College of Rheumatology criteria for the classification of SLE, E1 and disease activity was assessed by using the SLE disease activity index (SELENA-SLEDAI; Table <ref type="table" target="#tab_1">E1</ref>).</s></p><p><s>The ethics committee approved the use of tonsillar specimens for research purposes (permission EA1/107/10), and informed consent was obtained from patients.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Mice</head><p><s>C57BL/6, Rag1 2/2 , C57BL/6 CD45.1 1 , and OT-II mice were purchased from Jackson laboratories (Bar Harbor, Me).</s><s>Foxp3 RFP (Fir) and IL-10 eGFP (Tiger) reporter mice were generated at Yale University.</s><s>Age-and sex-matched littermates between 8 and 12 weeks of age were used.</s><s>Animal procedures were approved by the Institutional Animal Care and Use Committee of Yale University.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cell isolation</head><p><s>Human PBMCs and tonsillar mononuclear cells were isolated by using Ficoll-Hypaque gradient, according to published protocols.</s><s>Lymphocyte subsets were purified by means of cell sorting on a FACSAria (BD, San Jose, Calif) based on surface marker expression (purity of &gt;95%).</s><s>The J558-CD40L transfected cell line were kindly provided by A. Lanzavecchia (IRB, Bellinzona, Switzerland).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Flow cytometry</head><p><s>Human cells were stained with the following antibodies: CD3 (UCHT1), CD27 (M-T27), CD4 (RPA-T4), CD8 (RPA-T8), IgG (G18-145), CCR5 (27D), CCR6 (11A9), CD40L (TRAP1), PD-1 (MIH4), CTLA-4 (BNI3), CD25 (M-A251), IL-10 (JES-19F1), and IFN-g (B27) from BD; CD4 (VIT4) from Miltentyi Biotec (Bergisch Gladbach, Germany); CD8 (OKT8), CD19 (HIB19), CD127 (eBioRDR5), ICOS (ISA-3), FOXP3 (PCH101), and IL-21 (3A3-N2) from eBioscience (San Diego, Calif); and CD25 (BC96) from BioLegend (San Diego, Calif).</s><s>Biotinylated mAbs were revealed with streptavidin-allophycocyanin or streptavidin-allophycocyanin Cy7 (BD or eBioscience).</s><s>Murine cells were stained with anti-CD4 (GK1.5),</s><s>anti-PD-1 (RMP1-30), anti-CCR5 (HM-CCR5), anti-CCR6 (29-2I17), CD19 (6D5), CD45.2 (104), and anti-TCR (H57-597), all from BioLegend.</s><s>Samples were passed on a FACSCanto flow cytometer (BD) and analyzed with FlowJo software (TreeStar, Ashland, Ore).</s><s>T-cell cytokine production was measured after stimulation with 0.1 mmol/mL phorbol ester (phorbol 12-myristate 13-acetate or phorbol 12,13-dibutyrate) and 1 mg/mL ionomycin (Sigma-Aldrich, St Louis, Mo) in the presence of 10 mg/mL Brefeldin A (Sigma), and cells were fixed, permeabilized, stained, and analyzed by means of flow cytometry.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>B-cell helper and suppression assays</head><p><s>Human total (CD22 1 ) or naive (CD27 2 ) B cells from tonsils (3 3 10 4 ) were cocultured with 10 4 sorted populations of CD4 1 T cells in the presence of staphylococcal lymphotoxin B (SEB; 1 mg/mL, Sigma) in RPMI-5% low IgG serum.</s><s>In some experiments 10 4 cells of a CD40L-transfected cell line were added (kindly provided by A. Lanzavecchia) and IgG production by CCR5 2 IL-7R 2 control cells in the absence of exogenous CD40L was set as 100% B-cell help.</s><s>T R 1-like cells were sorted as CD4 1 CD25 2 IL-7R 2 CCR5 1 CCR6 2 , control cells as CD4 1 CD25 2 IL-7R 2 CCR5 2 CCR6 1 , and Treg cells as CD4 1 CD25 1 IL-7R 2 .</s><s>Concentrations of IL-10, CXCL13, and IgG in culture supernatants were measured on day 8 by means of ELISA (CXCL13: Biosupply, Italy; IL-10 and IgG: BD).</s><s>To determine B-cell proliferation, CD22 1 tonsillar B cells were carboxyfluorescein succinimidyl ester (CFSE) labeled (Sigma) and cocultured with T cells, and CFSE dilution was assessed by means of flow cytometry on day 8.</s><s>For B-cell suppression assays, sorted tonsillar CD27 2 B cells or total peripheral blood CD22 1 B cells were cocultured with Treg cell-sensitive CD4 1 CD25 2 B-helper T cells isolated according to CCR6 and IL-7R expression, SEB, and Treg cell subsets at a 1:1 ratio.</s><s>After 8 days, CXCL13, IgM (Sigma), and IgG levels in culture supernatants were measured by using ELISA.</s><s>To calculate the percentage of suppression, we set the percentage of IgG produced by B cells helped by T helper cells in the absence of Treg subsets as 0% of suppression.</s></p><p><s>For in vivo B-helper assays, Rag1 2/2 mice were reconstituted intravenously with 2 3 10 6 CD19 1 B cells and 5 3 10 5 purified OT-II T-cell populations.</s><s>CD4 1 T cells from spleens of untreated OT-IIxIL-10 eGFP xFoxp3 RFP mice were purified by means of cell sorting, expanded with anti-CD3 and anti-CD28 antibodies and IL-2, and then injected.</s><s>OVA-specific T R 1 cells were generated from OT-II CD4 1 T cells in vitro with anti-CD3 and anti-CD28 antibodies, IL-27, and TGF-b and purified according to IL-10 eGFP , CCR5, and PD-1 expression.</s><s>Twenty-four hours after reconstitution, mice were immunized with 50 mg of OVA per mouse in alum intraperitoneally.</s><s>Serum immunoglobulins were analyzed 12 days after immunization.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>T-cell suppression assay</head><p><s>Human CD4 1 naive T cells were sorted according to CD45RA expression and labeled with CFSE.</s><s>They were cocultured at a 1:1 ratio with sorted Treg cell subsets and allogeneic human myeloid CD1c 1 DCs at a 1:5 ratio.</s><s>After 5 days, cells were stained and analyzed for CFSE dilution by using fluorescence-activated cell sorting.</s><s>To calculate the percentage of suppression, we set undivided cells as 100% of suppression and the percentage of proliferating T cells in the absence of Treg cell subsets as 0% of suppression.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistics</head><p><s>Statistical significance was calculated by using the 2-tailed Student t test in case of Gaussian distribution; otherwise, we used the Mann-Whitney test for unpaired or the Wilcoxon test for paired groups.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head></head><label></label><figDesc><div><p><s>CCR5 and PD-1 strongly enriched for IL-10-producing T cells (Fig 1, G). Importantly, more than 40% of IL-7R 2 CCR5 1 PD-1 1 T cells produced IL-10 ex vivo, whereas IL-7R 2 CCR5 2 T cells lacked IL-10-producing capacities (Fig 1, F and G, and see Fig E2, A).</s><s>Moreover, purified T R 1-like cells produced IL-10 on stimulation with B cells (see Fig E2, C) and suppressed dendritic cell (DC)-induced naive CD4 1 T-cell proliferation (Fig 1, H, and see Fig E2, D), whereas CCR5 2 IL-7R</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head></head><label></label><figDesc><div><p><s>, in this article's Online Repository at www.jacionline.org)</s><s>and IgG secretion (Fig 2, A) or produce CXCL13 (see Fig E3, B), a chemokine secreted by B-helper T cells.</s><s>Conversely, CCR5 2 IL-7R 2 control cells (Fig 2, A) and CCR6 1 IL-7R 1 T cells (see Fig E2, C) provided B-cell help.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Tonsillar IL-7R 2</head><label>2</label><figDesc><div><p><s>CCR5 1 T R 1-like cells were Foxp3 2 (see Fig E3, D), but similar to CD25 1 Treg cells, they blocked IgG secretion and inhibited CXCL13 secretion by helper T cells (Fig 2, D).</s><s>However, neither T R 1-like cells nor CD25 1 Treg cells inhibited IgM secretion (Fig 2, D), suggesting that both Treg cell subsets selectively inhibited immunoglobulin isotype switching.</s><s>Consistently, patients with genetic defects in the CD40/CD40L pathway have impaired immunoglobulin class-switching and low IgG secretion but normal or increased IgM levels. 10</s><s>Notably, although IL-7R 2 T R 1-like cells block DC-induced T-cell proliferation through IL-10 6 and inhibition of IgG production was predominantly mediated by soluble factors (see Fig E3, E), IL-10 was not required for B-cell suppression (see Fig E3, F).</s><s>Moreover, blocking of neither TGF-b or ICOS ligand (Fig E3, G) nor CTLA-4, PD-1, or Fas (data not shown) relieved T R 1-mediated suppression of IgG production.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>FIG 1 .</head><label>1</label><figDesc><div><p><s>FIG 1. Identification and characterization of T R 1-like cells in human tonsils.</s><s>A, Frequency of CD4 1 T-cell subsets according to IL-7R and CD25 expression in blood and tonsils in representative donors of at least 7. B, IL-10 production by purified CD4 1 T-cell subsets (ie, in IL-7R 2 CD25 2 [IL-7R 2 ], IL-7R hi CD25 lo [IL-7R 1 ], and IL-7R lo CD25 hi T cells [Treg] cells) in blood (n 5 20) and tonsils (n 5 7).</s><s>C and D, Cytokine profile (Fig 1, C) and coreceptor expression (Fig 1, D) by using purified tonsillar T-cell subsets (n &gt; 4).</s><s>IL-10 1 and IL-10 2 IL-7R 2 cells were analyzed separately.</s><s>Bars represent the mean percentage of positive cells in the indicated subset.</s><s>E, CCR5 and PD-1 or CCR6 coexpression by IL-7R 2 IL-10 1 T R 1-like cells in 1 representative donor of 4. F, IL-10 production by IL-7R 2 T cells gated according to CCR5, PD-1, or CCR6 expression.</s><s>Bars indicate the mean percentage of IL-10 1 T cells in the indicated subset (n &gt; 6).</s><s>G, IL-10 production in CCR5 1 PD-1 1 or total CD4 1 CD25 2 IL-7R 2 T cells (n 5 10).</s><s>H, Inhibition of DC-induced CD4 1 T-cell proliferation by Treg cell subsets (n 5 3).</s><s>*P &lt; .05,</s><s>**P &lt; .005,</s><s>and ***P &lt; .0005.</s></p></div></figDesc><graphic coords="2,54.71,65.59,479.48,380.69" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>FIG 2 .</head><label>2</label><figDesc><div><p><s>FIG 2. T R 1-like cells regulate B-cell responses and are altered in patients with SLE.</s><s>A, IgG production by naive tonsillar B cells in the presence of the indicated T-cell subsets and SEB (n 5 9).</s><s>B, CD40L expression by the indicated CD4 1 T-cell subsets.</s><s>Histograms represent 1 representative donor of 4. C, Effect of exogenous CD40L on IgG production by naive B cells cocultured with the indicated T-cell subsets (n &gt; 4).</s><s>D, Effects of tonsillar Treg cell subsets on IgG, IgM, and CXCL13 production in cocultures of B cells and helper T cells (n 5 7).</s><s>E, OVA-specific serum IgG 1 concentrations in Rag 2/2 mice after cotransfer of B cells with the indicated CD4 1 T-cell subsets and immunization with OVA (n 5 6).</s><s>F, Frequencies of Treg cell subsets in the blood of healthy donors and patients with SLE with nonactive (SLEDAI low [&lt;6]) or active (SLEDAI mod/hi [&gt;5]) disease, as indicated in Table E1.</s><s>G, Effects of circulating Treg cell subsets on helper T cell-induced IgG production in patients with SLE (left panel; n 5 10) and healthy donors (right panel; n 5 6).</s><s>*P &lt; .05,</s><s>**P &lt; .005,</s><s>and ***P &lt; .0005.</s><s>ns, Not significant.</s></p></div></figDesc><graphic coords="3,68.83,65.59,443.51,365.44" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Fig 1 ,</head><label>1</label><figDesc><div><p><s>A and B), midface hypoplasia (Fig 1, B), micrognathia (Fig 1, B), and natal teeth (Fig 1, C). Limbs were short (Fig 1, D).</s><s>No eczematous lesions or other atopic features were observed.</s><s>Investigation revealed horseshoe kidney, atrial septal defect, intestinal malrotation, and bilateral exaggerated trochanter minor (Fig 1, E). Magnetic resonance imaging showed no microcephaly or intracerebral malformations.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>REFERENCE</head><label></label><figDesc><div><p><s>FIG E1.</s><s>Characteristics of T R 1-like cells.</s><s>A, IL-21, CTLA-4, ICOS, and CD40L expression in the indicated T-cell subsets in peripheral blood.</s><s>Bars show the mean percentage of positive cells in each subset (n &gt; 6).</s><s>B, Percentage of CD45RA 1 cells in the indicated tonsillar T-cell subsets (n 5 4).</s><s>C, CCR5 and PD-1 or CCR6 coexpression on purified tonsillar IL-7R 2 T cells that were gated on IL-10 1 cells in 1 representative donor of 3. *P &lt; .05,</s><s>**P &lt; .005,</s><s>and ***P &lt; .0005.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="6,108.23,65.59,372.46,218.15" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="7,98.70,65.59,383.75,327.01" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="8,102.50,65.59,383.75,337.21" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head></head><label></label><figDesc><div><p><s><ref type="bibr" target="#b1">2</ref></s></p></div></figDesc><table /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>TABLE E1 .</head><label>E1</label><figDesc><div><p><s>Characteristics of patients with SLESubjects 1 to 40 were analyzed in Fig 2, F, and subjects 41 to 50 were analyzed in Fig 2, G.a, Arthralgia; aa, active arthritis; al, alopecia; an, anemia; anti-dsDNA, anti-double-stranded DNA; anti-ENA, anti-extractable nuclear antigen; at, autoimmune thrombocytopaenia; aza, azathioprine; cya, cyclosporine; F, female; f, fever; fa, fatigue; hcq, hydroxychloroquine; La, anti-La/SSB; le, leukopenia; M, male; mmf, mycophenolate mofetil; mtx, methotrexate; mu, mucosal ulcers; n, nephritis; obs, organic brain syndrome; pred, prednisolone; RNP, anti-ribonucleoprotein; Ro, anti-Ro/SSA; ser, serositis; Sm, anti-Smith; sr, skin rash.</s><s>*Negative value, &lt;10 IU/mL; positive value, &gt;10 IU/mL.</s><s>Normal value, &gt;0.9 g/L.</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell></cell><cell>Disease</cell><cell>Clinical/laboratory</cell><cell></cell><cell></cell><cell>Anti-dsDNA*</cell><cell></cell><cell></cell><cell>Proteinuria</cell></row><row><cell cols="3">Subjects Age (y) Sex</cell><cell>duration (y)</cell><cell>manifestations</cell><cell>Therapy</cell><cell>SLEDAI</cell><cell>(IU/mL)</cell><cell>Anti-ENA</cell><cell>C3y (g/L)</cell><cell>(g/24 h)</cell></row><row><cell>1</cell><cell>40</cell><cell>F</cell><cell>6</cell><cell>aa, an, fa, a</cell><cell>pred, hcq, mtx</cell><cell>8</cell><cell>54</cell><cell>Sm</cell><cell>0.67</cell><cell>0</cell></row><row><cell>2</cell><cell>51</cell><cell>F</cell><cell>14</cell><cell>sr, a, fa</cell><cell>pred, mmf</cell><cell>2</cell><cell>9</cell><cell>Negative</cell><cell>1.0</cell><cell>0.1</cell></row><row><cell>3</cell><cell>43</cell><cell>F</cell><cell>10</cell><cell>mu, a</cell><cell>Aza</cell><cell>2</cell><cell>0</cell><cell>Negative</cell><cell>0.91</cell><cell>0</cell></row><row><cell>4</cell><cell>60</cell><cell>F</cell><cell>33</cell><cell>n, fa</cell><cell>pred, hcq, mmf</cell><cell>4</cell><cell>0</cell><cell>Sm, RNP</cell><cell>1.13</cell><cell>0.3</cell></row><row><cell>5</cell><cell>58</cell><cell>F</cell><cell>26</cell><cell>al, a</cell><cell>pred</cell><cell>2</cell><cell>10</cell><cell>Ro</cell><cell>1.2</cell><cell>0</cell></row><row><cell>6</cell><cell>49</cell><cell>F</cell><cell>17</cell><cell>mu, f, a</cell><cell>pred, hcq, mmf</cell><cell>3</cell><cell>5</cell><cell>Negative</cell><cell>1.0</cell><cell>0.1</cell></row><row><cell>7</cell><cell>20</cell><cell>F</cell><cell>1</cell><cell>n, ser, sr, f</cell><cell>pred, hcq, cya</cell><cell>17</cell><cell>692</cell><cell>Sm, RNP</cell><cell>0.53</cell><cell>1.34</cell></row><row><cell>8</cell><cell>56</cell><cell>F</cell><cell>24</cell><cell>sr, an</cell><cell>pred, hcq</cell><cell>2</cell><cell>6</cell><cell>Ro, La, RNP</cell><cell>1.16</cell><cell>0.12</cell></row><row><cell>9</cell><cell>39</cell><cell>M</cell><cell>19</cell><cell>n, an, fa</cell><cell>pred, hcq</cell><cell>6</cell><cell>224</cell><cell>Sm</cell><cell>0.9</cell><cell>0.67</cell></row><row><cell>10</cell><cell>25</cell><cell>F</cell><cell>2</cell><cell cols="2">aa, a, ser, sr, mu, fa pred, hcq, mtx</cell><cell>14</cell><cell>773</cell><cell>Ro</cell><cell>0.78</cell><cell>0.15</cell></row><row><cell>11</cell><cell>55</cell><cell>F</cell><cell>23</cell><cell>sr, fa, a</cell><cell>hcq</cell><cell>2</cell><cell>0</cell><cell>Sm, Ro</cell><cell>1.5</cell><cell>0</cell></row><row><cell>12</cell><cell>42</cell><cell>F</cell><cell>10</cell><cell>an, fa</cell><cell>pred</cell><cell>2</cell><cell>4</cell><cell>Sm, RNP</cell><cell>0.68</cell><cell>0</cell></row><row><cell>13</cell><cell>46</cell><cell>F</cell><cell>21</cell><cell>sr, fa, a</cell><cell>pred, aza</cell><cell>4</cell><cell>69</cell><cell>Ro</cell><cell>1.22</cell><cell>0</cell></row><row><cell>14</cell><cell>36</cell><cell>F</cell><cell>12</cell><cell>n, sr, f, le</cell><cell>pred</cell><cell>15</cell><cell>784</cell><cell>Sm, RNP, Ro, La</cell><cell>0.39</cell><cell>1.44</cell></row><row><cell>15</cell><cell>44</cell><cell>M</cell><cell>21</cell><cell>ser, an, a</cell><cell>pred, hcq, mmf</cell><cell>4</cell><cell>0</cell><cell>Negative</cell><cell>0.61</cell><cell>0</cell></row><row><cell>16</cell><cell>57</cell><cell>F</cell><cell>20</cell><cell>an, fa</cell><cell>pred</cell><cell>0</cell><cell>0</cell><cell>Sm, RNP</cell><cell>1.79</cell><cell>0.02</cell></row><row><cell>17</cell><cell>58</cell><cell>F</cell><cell>28</cell><cell>sr, le, fa, a</cell><cell>pred, hcq</cell><cell>5</cell><cell>113</cell><cell>Sm</cell><cell>1.55</cell><cell>0</cell></row><row><cell>18</cell><cell>27</cell><cell>F</cell><cell>1</cell><cell>sr, ser</cell><cell>pred, hcq, aza</cell><cell>10</cell><cell>468</cell><cell>Ro</cell><cell>0.64</cell><cell>0.41</cell></row><row><cell>19</cell><cell>60</cell><cell>F</cell><cell>30</cell><cell>at, fa, a</cell><cell>pred, hcq, mmf</cell><cell>4</cell><cell>35</cell><cell>Ro</cell><cell>1.32</cell><cell>0</cell></row><row><cell>20</cell><cell>44</cell><cell>F</cell><cell>16</cell><cell>sr, a</cell><cell>pred, hcq</cell><cell>2</cell><cell>10</cell><cell>Sm</cell><cell>1.07</cell><cell>0</cell></row><row><cell>21</cell><cell>41</cell><cell>M</cell><cell>11</cell><cell>an, fa, a</cell><cell>pred</cell><cell>0</cell><cell>0</cell><cell>Sm, RNP, Ro</cell><cell>1.53</cell><cell>0</cell></row><row><cell>22</cell><cell>32</cell><cell>F</cell><cell>1</cell><cell>n, f, ser, le, fa</cell><cell>pred, hcq, cya</cell><cell>16</cell><cell>882</cell><cell>RNP, Ro, La</cell><cell>0.47</cell><cell>1.82</cell></row><row><cell>23</cell><cell>38</cell><cell>F</cell><cell>10</cell><cell>at, f, a</cell><cell>pred, hcq, mmf</cell><cell>5</cell><cell>258</cell><cell>Ro</cell><cell>1.17</cell><cell>0.05</cell></row><row><cell>24</cell><cell>61</cell><cell>F</cell><cell>30</cell><cell>fa, a</cell><cell>hcq</cell><cell>0</cell><cell>0</cell><cell>RNP, Ro</cell><cell>1.76</cell><cell>0</cell></row><row><cell>25</cell><cell>30</cell><cell>F</cell><cell>1</cell><cell>n, le, sr</cell><cell>pred, hcq, cya</cell><cell>7</cell><cell>6</cell><cell>Ro, La</cell><cell>0.92</cell><cell>0.34</cell></row><row><cell>26</cell><cell>33</cell><cell>F</cell><cell>4</cell><cell>sr, an, fa, a</cell><cell>pred, hcq, aza</cell><cell>6</cell><cell>96</cell><cell>Sm</cell><cell>0.61</cell><cell>0</cell></row><row><cell>27</cell><cell>35</cell><cell>F</cell><cell>7</cell><cell>ser, mu</cell><cell>pred, aza</cell><cell>5</cell><cell>0</cell><cell>Sm, RNP</cell><cell>0.94</cell><cell>0.06</cell></row><row><cell>28</cell><cell>34</cell><cell>F</cell><cell>1</cell><cell>obs, ser, sr, fa</cell><cell>pred</cell><cell>14</cell><cell>874</cell><cell>Negative</cell><cell>0.90</cell><cell>0.06</cell></row><row><cell>29</cell><cell>39</cell><cell>F</cell><cell>11</cell><cell>n, al, fa, a</cell><cell>pred, cya</cell><cell>8</cell><cell>45</cell><cell>Negative</cell><cell>0.58</cell><cell>1.30</cell></row><row><cell>30</cell><cell>41</cell><cell>F</cell><cell>12</cell><cell>le, f, a, fa</cell><cell>pred, hcq, cya</cell><cell>5</cell><cell>378</cell><cell>Sm, RNP</cell><cell>0.62</cell><cell>0.1</cell></row><row><cell>31</cell><cell>35</cell><cell>F</cell><cell>10</cell><cell>n, sr, an, a</cell><cell>pred, hcq, mmf</cell><cell>14</cell><cell>96</cell><cell>Sm, Ro, La</cell><cell>0.47</cell><cell>1.65</cell></row><row><cell>32</cell><cell>47</cell><cell>F</cell><cell>16</cell><cell>aa, a, mu, sr, fa</cell><cell>pred, hcq, mtx</cell><cell>9</cell><cell>10</cell><cell>RNP, Ro</cell><cell>1.26</cell><cell>0.02</cell></row><row><cell>33</cell><cell>54</cell><cell>M</cell><cell>14</cell><cell>an, a, fa</cell><cell>pred</cell><cell>16</cell><cell>7</cell><cell>Sm</cell><cell>1.03</cell><cell>0.03</cell></row><row><cell>34</cell><cell>42</cell><cell>F</cell><cell>18</cell><cell>at, fa</cell><cell>pred, hcq</cell><cell>1</cell><cell>0</cell><cell>Ro, La</cell><cell>1.32</cell><cell>0</cell></row><row><cell>35</cell><cell>40</cell><cell>F</cell><cell>11</cell><cell>n, mu, al, fa</cell><cell>pred, mmf</cell><cell>12</cell><cell>112</cell><cell>Sm, Ro</cell><cell>0.61</cell><cell>1.03</cell></row><row><cell>36</cell><cell>37</cell><cell>F</cell><cell>1</cell><cell>n, sr, ser, f</cell><cell>pred, hcq, cya</cell><cell>13</cell><cell>245</cell><cell>Ro</cell><cell>0.77</cell><cell>0.96</cell></row><row><cell>37</cell><cell>59</cell><cell>F</cell><cell>23</cell><cell>sr, a</cell><cell>pred, hcq</cell><cell>2</cell><cell>0</cell><cell>Negative</cell><cell>1.0</cell><cell>0.04</cell></row><row><cell>38</cell><cell>28</cell><cell>F</cell><cell>2</cell><cell>n, fa, a</cell><cell>pred, hcq, mmf</cell><cell>12</cell><cell>646</cell><cell>Sm, RNP</cell><cell>0.68</cell><cell>1</cell></row><row><cell>39</cell><cell>43</cell><cell>F</cell><cell>20</cell><cell>mu, a</cell><cell>pred, hcq</cell><cell>2</cell><cell>8</cell><cell>Sm</cell><cell>1.72</cell><cell>0</cell></row><row><cell>40</cell><cell>62</cell><cell>F</cell><cell>24</cell><cell>ser, f, fa</cell><cell>pred, aza</cell><cell>3</cell><cell>0</cell><cell>Sm, Ro, La</cell><cell>0.96</cell><cell>0.02</cell></row><row><cell>41</cell><cell>23</cell><cell>F</cell><cell>0</cell><cell>n, sr, an, a</cell><cell>//</cell><cell>14</cell><cell>872</cell><cell>Sm, RNP</cell><cell>0.38</cell><cell>1.86</cell></row><row><cell>42</cell><cell>34</cell><cell>F</cell><cell>10</cell><cell>n, mu, al, fa</cell><cell>pred, mmf, hcq</cell><cell>12</cell><cell>114</cell><cell>Ro</cell><cell>0.65</cell><cell>0.9</cell></row><row><cell>43</cell><cell>28</cell><cell>F</cell><cell>6</cell><cell>ser, aa, a, f</cell><cell>pred, hcq</cell><cell>11</cell><cell>96</cell><cell>Negative</cell><cell>0.77</cell><cell>0</cell></row><row><cell>44</cell><cell>29</cell><cell>F</cell><cell>4</cell><cell cols="2">aa, a, ser, sr, mu, fa pred, hcq, mtx</cell><cell>14</cell><cell>321</cell><cell>Sm, Ro</cell><cell>0.54</cell><cell>0.02</cell></row><row><cell>45</cell><cell>37</cell><cell>F</cell><cell>10</cell><cell>an, fa</cell><cell>hcq, mmf</cell><cell>0</cell><cell>0</cell><cell>Sm, Ro, La</cell><cell>0.96</cell><cell>0</cell></row><row><cell>46</cell><cell>43</cell><cell>F</cell><cell>4</cell><cell>ser, f, fa</cell><cell>pred, mtx</cell><cell>3</cell><cell>8</cell><cell>Negative</cell><cell>1</cell><cell>0.02</cell></row><row><cell>47</cell><cell>38</cell><cell>F</cell><cell>5</cell><cell>fa, a</cell><cell>hcq</cell><cell>0</cell><cell>0</cell><cell>Ro</cell><cell>1.23</cell><cell>0</cell></row><row><cell>48</cell><cell>47</cell><cell>F</cell><cell>8</cell><cell>sr, a</cell><cell>hcq</cell><cell>2</cell><cell>4</cell><cell>Sm</cell><cell>1.18</cell><cell>0</cell></row><row><cell>49</cell><cell>46</cell><cell>F</cell><cell>7</cell><cell>an, fa</cell><cell>mmf</cell><cell>2</cell><cell>0</cell><cell>Negative</cell><cell>1.02</cell><cell>0.03</cell></row><row><cell>50</cell><cell>50</cell><cell>F</cell><cell>8</cell><cell>fa, an</cell><cell>hcq, aza</cell><cell>0</cell><cell>0</cell><cell>Sm</cell><cell>0.98</cell><cell>0</cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">J ALLERGY CLIN IMMUNOLJANUARY 2016</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">J ALLERGY CLIN IMMUNOL VOLUME 137, NUMBER 1 LETTERS TO THE EDITOR 321</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">J ALLERGY CLIN IMMUNOL VOLUME 137, NUMBER 1</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">J ALLERGY CLIN IMMUNOL JANUARY 2016 321.e3 LETTERS TO THE EDITOR</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Federica Facciotti, PhD a Nicola Gagliani, PhD c * Barbara H€ aringer, PhD b,d * Johanna Sophie Alfen, PhD</s></p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Interleukin-10 and the interleukin-10 receptor</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">W</forename><surname>Moore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>De Waal Malefyt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Coffman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Garra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Annu Rev Immunol</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="683" to="765" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Biology of interleukin-10</title>
		<author>
			<persName><forename type="first">R</forename><surname>Sabat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Grutz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Warszawska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kirsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Witte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Wolk</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cytokine Growth Factor Rev</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="331" to="344" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Foxp31 follicular regulatory T cells control the germinal center response</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Linterman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Pierson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kallies</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kawamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">F</forename><surname>Rayner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Med</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="975" to="982" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">CD46-induced human Treg enhance B-cell responses</title>
		<author>
			<persName><forename type="first">A</forename><surname>Fuchs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Atkinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Fremeaux-Bacchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Kemper</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Immunol</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="3097" to="3109" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Distinct regulation of IgE, IgG4 and IgA by T regulatory cells and toll-like receptors</title>
		<author>
			<persName><forename type="first">F</forename><surname>Meiler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Klunker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zimmermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Akdis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Akdis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="1455" to="1463" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Identification and characterization of IL-10/IFN-gamma-producing effector-like T cells with regulatory function in human blood</title>
		<author>
			<persName><forename type="first">B</forename><surname>Haringer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Lozza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Steckel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Geginat</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">206</biblScope>
			<biblScope unit="page" from="1009" to="1017" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Loss of IL-7 receptor alpha on CD41 T cells defines terminally differentiated B cell-helping effector T cells in a B cell-rich lymphoid tissue</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">W</forename><surname>Lim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Kim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">179</biblScope>
			<biblScope unit="page" from="7448" to="7456" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">CCR6 is expressed on an IL-10-producing, autoreactive memory T cell population with context-dependent regulatory function</title>
		<author>
			<persName><forename type="first">L</forename><surname>Rivino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Gruarin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Haringer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Steinfelder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Lozza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Steckel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">207</biblScope>
			<biblScope unit="page" from="565" to="577" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Noelle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Ledbetter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Aruffo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunol Today</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="431" to="433" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Hyper immunoglobulin M syndrome due to CD40 deficiency: clinical, molecular, and immunological features</title>
		<author>
			<persName><forename type="first">V</forename><surname>Lougaris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Badolato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ferrari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Plebani</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunol Rev</title>
		<imprint>
			<biblScope unit="volume">203</biblScope>
			<biblScope unit="page" from="48" to="66" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn&apos;s disease</title>
		<author>
			<persName><forename type="first">P</forename><surname>Desreumaux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Foussat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Allez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Beaugerie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Hebuterne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Bouhnik</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">143</biblScope>
			<biblScope unit="page" from="e1" to="2" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<monogr>
		<title level="m" type="main">Available online</title>
		<idno type="DOI">10.1016/j.jaci.2015.06.044</idno>
		<ptr target="http://dx.doi.org/10.1016/j.jaci.2015.06.044" />
		<imprint>
			<date type="published" when="2015-08-25">August 25. 2015</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
